Risk of suboptimal hormone replacement therapy for young hypogonadal women and transgender women in the wake of the Joint BMS FSRH RCGP RCOG SfE and RCN Women's Health Forum safety alert.
Yaasir H MamoojeeAnna L MitchellRichard QuintonPublished in: Clinical endocrinology (2023)
Keyphrases
- replacement therapy
- polycystic ovary syndrome
- pregnancy outcomes
- smoking cessation
- healthcare
- public health
- type diabetes
- insulin resistance
- mental health
- breast cancer risk
- pregnant women
- adipose tissue
- human immunodeficiency virus
- health information
- middle aged
- clinical decision support
- human health
- electronic health record
- hiv testing